MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    End-of-life care management in Parkinson’s disease: a nationwide survey of French healthcare practitioners’ experiences and perceptions

    A. Lagarde, A. Camm Chapel, T. Cognard, M. Auffret (Paris, France)

    Objective: To describe the personal experiences and perceptions of healthcare practitioners (HCP) involved in the terminal management of people diagnosed with Parkinson's disease (PD) Background:…
  • 2025 International Congress

    Integrating Counterclockwise Theory, Mental Imagery, and Art Therapy for Parkinson’s Disease: A Proposed Protocol for Motor and Non-motor Symptom Management

    WJ. Hur, HR. Yoo, MS. Park, JW. Seo, JY. Hur (Daejeon, Republic of Korea)

    Objective: This review/protocol proposal explores whether combining three concepts Counterclockwise theory, Imagery training, and Art therapy can improve motor symptoms and enhance the quality of…
  • 2025 International Congress

    Access to Allied Health Services by People Living with Parkinson’s Disease: A Qualitative Study

    C. Wong, S. Dennis, N. Allen, S. Paul (Camperdown, Australia)

    Objective: To determine the referral patterns of people with Parkinson’s disease (PwPD) to allied health from their perspective. Background: Allied health interventions can improve impairments…
  • 2025 International Congress

    P2P Therapeutics Platform Trial in Stage 2B Neuronal Alpha-Synuclein Disease: Study Design and Statistical Considerations

    T. Simuni, C. Coffey, A. Siderowf, C. Tanner, M. Brumm, S. Chowdhury, T. Sherer, C. Kopil, K. Kieburtz, C. Allen-Savietta, B. Wendelberger, A. Crawford, T. Tropea, K. Fabrizio, H. Whalen, K. Marek (Chicago, USA)

    Objective: To describe the study design and timeline of a platform interventional study in Neuronal α-Synuclein Disease (NSD). Background: The recent description of the biological…
  • 2025 International Congress

    Smartphone-based digital assessments in the LUMA trial of BIIB122 for early-stage Parkinson’s disease

    R. Llorens Arenas, J. Edgerton, E. Bartholomé, S. Belachew, M. Gifford, J. Guo, B. Hersh, D. Jennings, C. Kanzler, E. Koca, M. Pang, O. Reyes, C. Shen, M. Wald, N. Woody, C. Mazzá (Cambridge, USA)

    Objective: To evaluate the sensitivity of routine smartphone-based performance assessments in the free-living environment as part of a randomized clinical trial in Parkinson’s disease (PD).…
  • 2025 International Congress

    Evaluation of Impact of Helicobacter Pylori Eradication on Symptomatology and Quality of Life in Parkinson’s Disease

    A. Kakkar, G. Vishwas, S. Mehta, S. Pattanaik, S. Bhattacharyya, V. Sharma, M. Modi (Chandigarh, India)

    Objective: This study aimed to determine the effects of Helicobacter Pylori(HP) eradication treatment on motor and non-motor symptoms and quality of life of PD patients…
  • 2025 International Congress

    Quality of Life Improvements in Parkinson’s Disease for Those Treated with Photobiomodulation Plus Exercise: A Sham-Controlled Study

    A. Saltmarche, O. Hares, A. Liebert, B. Bicknell, M. Naeser, G. Heller, J. Sykes, K. Togeretz, A. Namini, G. Herkes (Toronto, Canada)

    Objective: To assess whether exercise alone, or exercise combined with photobiomodulation (PBM) can improve the health-related quality of life (QoL) for people with Parkinson’s disease…
  • 2025 International Congress

    Random-Order Crossover Trial Assessing the Safety, Feasibility and Exploratory Efficacy of Two Mediterranean-Ketogenic Nutritional Interventions in Parkinson’s Disease

    K. Tosefsky, J. Lam, Y. Wang, A. Kuan, S. Appel-Cresswell (Vancouver, Canada)

    Objective: Assess the feasibility, safety and exploratory efficacy of two Mediterranean-ketogenic dietary interventions in individuals with Parkinson’s disease (PD). Background: Both Mediterranean and ketogenic diets…
  • 2025 International Congress

    A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the NLRP3 Inhibitor Vent-02 in Patients with Mild to Moderate Parkinson’s Disease

    A. Matta, X. Valencia, K. Pike, L. Warner, O. Spiegelstein, M. Bigal (Waltham, USA)

    Objective: To describe the innovative Phase 2 study design aimed to investigate vent-02 in the treatment of PD. Background: NLRP3 hyperactivation plays a critical role…
  • 2025 International Congress

    Ferritin-related Brain Iron Deposition in Parkinson’s Disease Involves α-Synuclein Pathology

    L. Luo, D. Su, Z. Yu, T. Feng (Beijing, China)

    Objective: To investigate plasma neuron-derived ferritin-containing extracellular vesicles (NDFEVs) differences between Parkinson’s disease (PD) patients and controls, assess their association with brain iron deposition, and explore the…
  • « Previous Page
  • 1
  • …
  • 209
  • 210
  • 211
  • 212
  • 213
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley